started · updated
Cychlorphine synthetic opioid identified in U.S. drug supply
Health and law enforcement officials are issuing warnings regarding cychlorphine, an emerging synthetic opioid appearing in the illicit drug supply across the United States. Part of a class of substances known as “orphines,” cychlorphine is reported to be up to 10 times more potent than fentanyl.
The Office of National Drug Control Policy (ONDCP) has documented 106 drug-supply reports across 10 states, with detections in all four U.S. Census regions. The substance has been linked to at least 55 deaths between 2025 and 2026, with high prevalence noted in Ohio, Texas, and Tennessee. It is often found alone or mixed with fentanyl, methamphetamine, cocaine, and counterfeit prescription pills.
A critical concern is that cychlorphine is not detected by common fentanyl test strips or routine hospital opioid urine screens. Because of its extreme potency, overdoses may require multiple doses of naloxone. While existing overdose-reversal medications like naloxone remain effective, officials urge clinicians and first responders to treat symptoms—such as respiratory depression, unresponsiveness, and pinpoint pupils—rather than relying on standard drug tests.
Entities
Drug Enforcement Administration · Office of National Drug Control Policy · United States